Announcements Trials
Browse Landscape

Phase

Phase 2 13Phase 1 12Phase NA 11Phase 1/2 9Phase EARLY_PHASE1 6Phase 3 1Phase 2/3 1

Status

Recruiting 17Completed 16Active not recruiting 9Terminated 8Withdrawn 6Unknown 6Not yet recruiting 3

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

CNS 6

Conditions

Breast Neoplasms 15Neoplasms 11Pancreatic Neoplasms 10Prostatic Neoplasms 7Glioma 6Squamous Cell Carcinoma of Head and Neck 5Ovarian Neoplasms 5Head and Neck Neoplasms 5Glioblastoma 5Carcinoma, Non-Small-Cell Lung 5Triple Negative Breast Neoplasms 4Sarcoma 4Polycystic Ovary Syndrome 4Colonic Neoplasms 4Obesity 3Neoplasm Metastasis 3Multiple Myeloma 3Melanoma 3Lung Neoplasms 3Carcinoma, Intraductal, Noninfiltrating 3Brain Neoplasms 3Pain, Postoperative 2Lymphoma 2Fallopian Tube Neoplasms 2Esophageal Neoplasms 2Endometrial Neoplasms 2Depression 2Cholangiocarcinoma 2Central Nervous System Neoplasms 2Carcinoma, Renal Cell 2

Interventions

pembrolizumab 1orludodstat 1fluciclovine F-18 1abemaciclib 1Topotecan 1Temozolomide 1Standard of Care 1Radiotherapy 1Pemetrexed 1Magnetic Resonance Imaging 1Gemcitabine 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Withdrawn × Glioma × Clear all
NCT05054400 2023-09-01

Study of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MR

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Withdrawn
CNS

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms

NCT05061251 2022-01-11

Surgical Window of Opportunity Study of Orally Administered BAY 2402234 in Recurrent Glioma

University of Texas Southwestern Medical Center

Phase EARLY_PHASE1 Withdrawn
CNS

Glioma

NCT04220892 2020-07-31

Pilot Study of Pembrolizumab Combined With Pemetrexed or Abemaciclib for High Grade Glioma

Saint John's Cancer Institute

Phase EARLY_PHASE1 Withdrawn
CNS

Glioma

NCT04051047 2019-11-27

Gemcitabine in Newly-Diagnosed Diffuse Midline Glioma

University of Michigan Rogel Cancer Center

Phase EARLY_PHASE1 Withdrawn
CNS

Diffuse Intrinsic Pontine Glioma, Glioma

NCT03193463 2019-03-01

Intratumorally-Administered Topotecan Using CED in High Grade Glioma Undergoing Stereotactic Biopsy

Case Comprehensive Cancer Center

Phase EARLY_PHASE1 Withdrawn
CNS

Glioma

NCT02976441 2017-02-20

Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas

Washington University School of Medicine

Phase EARLY_PHASE1 Withdrawn
CNS

Astrocytoma, Ependymoma, Glioma, Oligodendroglioma, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡